Subheet Kumar Jain

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Top Venues

Current drug targets

AAPS PharmSciTech

Drug and chemical toxicology

Food & function

This page only lists publications with an associated author ORCID identifier.

Publications

Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery. Current drug targets (2024)
Bindu Soni, Riya Shivgotra, Karan Trehan, Aashveen Chhina, Muskaan Saini, Subheet Kumar Jain, Shubham Thakur
An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis. Current drug targets 25 (5) (2024)
Shubham Thakur, Harmanpreet Singh, Sunil Sharma, Manjot Kaur, Amrinder Singh, Arvinder Kaur, Subheet Kumar Jain
Pre-clinical and cellular safety assessment of oral administered DHA rich microalgae oil from Schizochytrium sp. (Strain ATCC-20889): acute, sub-chronic and genotoxicity. Drug and chemical toxicology (2024)
Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery. Current drug targets 25 (5) (2024)
Shagun Saini, Bindu Soni, Manjot Kaur, Shubham Thakur, Riya Shivgotra, Navid Reza Shahtaghi, Subheet Kumar Jain
Propellant Free Pressurized Spray System of Etodolac to Manage Acute Pain Conditions: In Vitro and In Vivo Evaluation. AAPS PharmSciTech 25 (5) (2024)
Bindu Soni, Riya Shivgotra, Karan Trehan, Aashveen Chhina, Muskaan Saini, Subheet Kumar Jain, Shubham Thakur
An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis. Current drug targets (2024)
Navid Reza Shahtaghi, Bindu Soni, Hossamaldeen Bakery, Samira Bigdelitabar, Subheet Kumar Jain
Beta-Hydroxybutyrate: A Supplemental Molecule for Various Diseases. Current drug targets (2024)
Bindu Soni, Riya Shivgotra, Karan Trehan, Aashveen Chhina, Muskaan Saini, Subheet Kumar Jain, Shubham Thakur
An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis. Current drug targets 25 (5) (2024)
Hossamaldeen Bakrey, Riya Shivgotra, Abdulkadir Abdu, Bindu Soni, Navid Reza Shahtaghia, Subheet Kumar Jain, Shubham Thakur
Use of Total Parenteral Nutrition (TPN) as a Vehicle for Drug Delivery. Current drug targets 25 (5) (2024)
Harjeet Singh, Harmanpreet Singh, Sunil Sharma, Harmanpreet Kaur, Arvinder Kaur, Satwinderjeet Kaur, Sandeep Kaur, Nikhil Shri Sahajpal, Alka Chaubey, Navid Reza Shahtaghi, Inderjeet Kaur, Subheet Kumar Jain
Genotoxic and mutagenic potential of 7-methylxanthine: an investigational drug molecule for the treatment of myopia. Drug and chemical toxicology (2023)
Shubham Thakur, Rasdeep Kour, Satwinderjeet Kaur, Subheet Kumar Jain
Spray-Dried Microspheres of Carboplatin: Technology to Develop Longer-Acting Injectable with Improved Physio-Chemical Stability, Toxicity, and Therapeutics. AAPS PharmSciTech 23 (5) (2022)
Shubham Thakur, Amrit Pal Kaur, Kanwardeep Singh, Rajpinder Kaur, Manpreet Kaur, Subheet Kumar Jain
Reference Range of Plasma Fatty Acids in North Indian Pregnant Population. Indian journal of clinical biochemistry : IJCB 38 (4) (2022)
Amrinder Singh, Shubham Thakur, Narpinder Singh, Satwinderjeet Kaur, Subheet Kumar Jain
Novel Gellan Gum-Based In Situ Nanovesicle Formulation of Docetaxel for Its Localized Delivery Using Depot Formation. AAPS PharmSciTech 22 (5) (2021)
Neha Panchal, Manjot Kaur, Abhay Tharmatt, Shubham Thakur, Subheet Kumar Jain
Development, Characterization and Evaluation of Parenteral Formulation of Diclofenac Sodium. AAPS PharmSciTech 21 (6) (2020)
Harmanpreet Singh, Chateshwar Kumar, Narpinder Singh, Surinder Paul, Subheet Kumar Jain
Nanoencapsulation of docosahexaenoic acid (DHA) using a combination of food grade polymeric wall materials and its application for improvement in bioavailability and oxidative stability. Food & function 9 (4) (2018)